Jay Hatfield, Infra-Cap CEO, joins 'Power Lunch' to discuss stock plays for three stocks.

UNH's third-quarter earnings benefit on the back of client wins in the Optum Rx sub-unit, partly offset by an elevated operating expense level.

Cyberattacks can have a deceptively longtail impact, as UnitedHealth's Tuesday (Oct. 15) earnings call revealed. In February 2024, UnitedHealth Group Inc.'s Change Healthcare unit suffered a far-re...

UnitedHealth (UNH) gave back all its gains from the past three months following its earnings miss and narrowed EPS guidance. Meanwhile, Walgreens (WBA) rallied after announcing more than a thousand...

UnitedHealth Group (UNH) came out with quarterly earnings of $7.15 per share, beating the Zacks Consensus Estimate of $7.02 per share. This compares to earnings of $6.56 per share a year ago.

The healthcare services provider post third-quarter adjusted earnings of $7.15 a share, beating analysts' estimates of $7.

UnitedHealth Group (UNH) will report third-quarter earnings before the opening bell Tuesday, with investors likely to be watching for continued growth from its Optum division.

UnitedHealth Group Incorporated's Q3 earnings report is due October 15th. We expect sustained gross income from a favorable insurance pricing environment. However, claims remain unpredictable. Lowe...

CVS Health and UnitedHealth Group have asked U.S. Federal Trade Commission chair Lina Khan and commissioners Rebecca Kelly Slaughter and Alvaro Bedoya to disqualify themselves from an FTC lawsuit t...

The FTC sued UnitedHealth Group's Optum unit, CVS Caremark and Cigna's Express Scripts for allegedly steering diabetes patients towards higher priced insulin.

Smaller rivals to UnitedHealth's tech unit Change Healthcare say they are signing longer-term contracts with hospitals and other customers who had temporarily switched from the company after Februa...

UnitedHealth was our top pick for 2024 due to its strong operating plan and attractive valuation. Despite trailing the S&P 500 by 11%, the stock's long-term potential remains as industry headwinds,...

UnitedHealth's aggressive M&A strategy, including the $13 billion acquisition of Change Healthcare, has strengthened its data analytics and improved margins, justifying a 'Strong Buy' rating. Despi...

UnitedHealth Group remains a solid buy-and-hold type of stock for the long-term dividend growth investor. Shares have recently touched a new all-time high; despite that, based on earnings growth go...

UnitedHealth's dividend yield of 1.4% looks modest but not when you factor in its growth. The company has nearly doubled its payout in just five years.